EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,255,000 | -56.4% | 18,102 | -52.5% | 0.02% | -60.0% |
| Q2 2018 | $2,880,000 | +76.7% | 38,070 | +23.1% | 0.04% | +60.0% |
| Q1 2018 | $1,630,000 | -16.0% | 30,929 | -14.9% | 0.02% | -10.7% |
| Q4 2017 | $1,941,000 | -49.2% | 36,327 | -43.3% | 0.03% | -48.1% |
| Q3 2017 | $3,819,000 | -0.7% | 64,042 | +31.4% | 0.05% | -6.9% |
| Q2 2017 | $3,845,000 | -28.8% | 48,741 | -25.1% | 0.06% | -36.3% |
| Q1 2017 | $5,398,000 | +26.9% | 65,085 | +21.4% | 0.09% | +11.0% |
| Q4 2016 | $4,253,000 | -27.1% | 53,600 | -35.7% | 0.08% | -20.4% |
| Q3 2016 | $5,838,000 | +54.5% | 83,407 | -14.4% | 0.10% | +43.1% |
| Q2 2016 | $3,778,000 | -53.1% | 97,407 | -51.0% | 0.07% | -53.8% |
| Q1 2016 | $8,056,000 | -58.5% | 198,907 | -9.1% | 0.16% | -54.1% |
| Q4 2015 | $19,410,000 | -4.3% | 218,907 | -20.1% | 0.34% | -0.3% |
| Q3 2015 | $20,277,000 | -55.1% | 273,907 | -51.0% | 0.34% | +5.6% |
| Q2 2015 | $45,186,000 | +702.6% | 558,814 | +315.8% | 0.32% | +303.8% |
| Q1 2015 | $5,630,000 | +284.8% | 134,407 | +42.4% | 0.08% | +263.6% |
| Q4 2014 | $1,463,000 | -14.7% | 94,407 | -32.6% | 0.02% | -12.0% |
| Q3 2014 | $1,715,000 | – | 140,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |